Prevo, R., Fokas, E., Reaper, P. M., Charlton, P. A., Pollard, J. R., McKenna, W. G., . . . Brunner, T. B. (2012). The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer biology & therapy, 13(11), 1072-1081. https://doi.org/10.4161/cbt.21093
Citace podle Chicago (17th ed.)Prevo, Remko, Emmanouil Fokas, Philip M. Reaper, Peter A. Charlton, John R. Pollard, W. Gillies McKenna, Ruth J. Muschel, a Thomas B. Brunner. "The Novel ATR Inhibitor VE-821 Increases Sensitivity of Pancreatic Cancer Cells to Radiation and Chemotherapy." Cancer Biology & Therapy 13, no. 11 (2012): 1072-1081. https://doi.org/10.4161/cbt.21093.
Citace podle MLA (9th ed.)Prevo, Remko, et al. "The Novel ATR Inhibitor VE-821 Increases Sensitivity of Pancreatic Cancer Cells to Radiation and Chemotherapy." Cancer Biology & Therapy, vol. 13, no. 11, 2012, pp. 1072-1081, https://doi.org/10.4161/cbt.21093.